CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81,921 enrolled
Drug / intervention
Antipsychotic +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02775864
NCT02775864N/ACompleted
CompareCT.gov

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

New York State Psychiatric Institute·observational·Posted May 18, 2016·Updated May 1, 2024

In Brief

An observational study evaluating Antipsychotic, Antidepressant, and 2 other interventions for Schizophrenia and Schizoaffective Disorder. Completed, enrolled 81,921 participants.

Detailed Summary

The study is a retrospective cohort study of adults with schizophrenia that will compare outcomes of new users of alternative psychotropic medication strategies using 10 years of Medicaid data. The primary comparative effectiveness analyses will focus on subgroups of patients with schizophrenia facing common clinical situations.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Schizoaffective Disorder
Countries--
CollaboratorsRutgers University, Patient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 18, 2016
Enrollment StartJul 1, 2015
Primary CompletionApr 1, 2018
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.1 years ago

Interventions

Antipsychoticdrug

New initiation of any antipsychotic medication

Antidepressantdrug

New initiation of any antidepressant medications

Benzodiazepinedrug

New initiation of any benzodiazepine

Mood stabilizerdrug

New initiation of lithium or any mood stabilizing anti-epileptic drug